When Compensation Becomes Unsustainable: Rethinking Medical Liability in ENT. [PDF]
Erdağ TK.
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Health insurance policy enforcement and catastrophic health expenditure: a case study in Sichuan province, China. [PDF]
Liu W, Huang G.
europepmc +1 more source
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All
Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic +2 more
wiley +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Access and Reimbursement for Artificial Intelligence in Radiology: A Central Asian Perspective. [PDF]
Dautov T +3 more
europepmc +1 more source
Institutional design features of health insurance subsidy programmes in Africa: a narrative review. [PDF]
Wafula A, Barasa E, Maritim B.
europepmc +1 more source
Estimating the adverse selection and moral hazard in Urban and Rural Resident Basic Medical Insurance of China: a semi-parametric estimation approach. [PDF]
Wu Y, Xu J.
europepmc +1 more source
Reimbursement Policies of Swiss Health Insurances for the Surgical Treatment of Symptomatic Abdominal Tissue Excess After Massive Weight Loss: A Retrospective Cohort Study. [PDF]
Pruzzo V +6 more
europepmc +1 more source

